The History of EBO2 (EBOO): From Siena to US Clinics
EBO2 (also called EBOO) began in a hospital in Siena, Italy. A group of nephrology and physiology researchers there started ozonating blood in an extracorporeal circuit in 1990 [1], described the method in 1999 [2], published the first report in patients in 2000 [3], and ran a randomized trial in 2005 [1]. Today clinics across the United States offer it: as of November 18, 2026, our clinic directory lists 175 of them.
This guide tells that story in order, with a dated timeline for each stage. Every date comes from the paper or page cited beside it.
Where ozone therapy came from
Ozone has a long history in medicine. A 2025 review of that history dates the first recorded observation of ozone to 1785, its naming by Christian Friedrich Schönbein to 1840, and the medical use of ozonized oils to 1859 [4].
The direct ancestor of EBO2 is major autohemotherapy, a batch method of treating a person’s own blood with ozone. Two sources date its start a few years apart: a 2022 paper says it was first described in 1954 by Wehrli and Steinbart [6], and the 2025 review credits Hans Wolff with introducing it by 1961 [4].
The idea of treating blood in a circuit outside the body is old too. PubMed indexes a 1960 German paper titled “The development of extracorporeal therapy of blood with oxygen, UV rays and ozone” [19]. We could read only its title, so we cannot say how it relates to the later Siena work.
By 2000 the Siena group could write that ozone autohemotherapy had been in use “for four decades with encouraging results”, and it noted that clinical studies were lacking [3]. EBOO was designed to scale the batch method up with a continuous circuit [5].
The Siena researchers, 1990 to 2011
EBOO came out of the University of Siena and the nephrology and dialysis department of the Siena hospital. The nephrologist Nicola Di Paolo led the clinical papers, and the physiologist Velio Bocci was a co-author of most of them [1][2][3]. They began “using extracorporeal circulation to ozonate blood” in 1990, aiming to amplify the results of ozone autohemotherapy [1].
| Date | What happened | Source |
|---|---|---|
| 1990 | The Siena group begins ozonating blood in an extracorporeal circuit | [1] |
| 1999 | First methods paper: tests in saline, pig blood and sheep, and the choice of hydrophobic, ozone-resistant hollow fibers for the gas exchanger | [2] |
| 2000 | First report in patients, described as “without side-effects” | [3] |
| 2001 | Several oxygenator-ozonators compared and one type selected; the more biocompatible ones treat up to 5 liters in about an hour | [7] |
| 2002 | A case report on a dialysis patient with necrotizing fasciitis; the authors write that EBOO “is used routinely in our hospital” | [8] |
| 2005 | Randomized trial in 28 people with peripheral artery disease, EBOO compared with intravenous prostacyclin | [1] |
| 2005 | Review by the developers: more than 1,200 treatments in 82 patients | [5] |
| 2007 | A purpose-built gas exchanger, L001, tested in saline | [9] |
| 2010 | Four dialysis filters tested as ozone gas exchangers | [10] |
| 2011 | Bocci’s group reviews the methods of giving oxygen-ozone, EBOO among them | [11] |
What the Siena group published
The first patients. The 2000 report begins with one of the authors, who volunteered. He reported that two lipomas were gone after six treatments. A patient with Madelung disease and several patients with atherosclerotic vascular disease followed, and the authors described the treatment as “without side-effects” [3].
Routine hospital use. In 2002 the group reported on a dialysis patient with necrotizing fasciitis. In that paper the authors write that EBOO “is no longer in the experimental stage and is used routinely in our hospital” [8].
The trial. In 2005 the group published a randomized trial in 28 people with peripheral artery disease, comparing EBOO with intravenous prostacyclin. The paper records no side effects in 210 EBOO treatments [1]. It is a small study, and it is the one randomized trial of the procedure in our sources. Our guide to what the published research reports covers its findings.
The protocol. A review the same year summed up the experience: more than 1,200 treatments in 82 patients, up to 4,800 mL of blood an hour at an ozone concentration of 0.5 to 1 µg/mL, and a standard course of 14 one-hour sessions over 7 weeks [5].
In 2011 Bocci’s group described EBOO as “a procedure to be used in emergency conditions such as PAD stage 4”, run by “technicians specialized in extravascular blood circulation” [11]. PAD is peripheral artery disease, the condition the 2005 trial studied.
How the equipment evolved
The gas exchanger is the part of the circuit where blood meets the oxygen-ozone mix, and much of the Siena work went into it.
The 1999 paper tested the circuit in saline, in pig blood, and in sheep. The group found dialysis membranes “unsuitable because they are hydrophilic and vulnerable to O3” and adopted hydrophobic, ozone-resistant hollow fibers. It called heparin “not an ideal anticoagulant” for this circuit and used sodium citrate [2].
In 2001 the group compared several oxygenator-ozonators and selected one type. The more biocompatible oxygenators could treat up to 5 liters of blood in about an hour, “making the treatment of critical patients feasible” [7]. By 2005 the developers described treating up to 4,800 mL an hour [5].
A purpose-built gas exchanger, L001, followed in 2007 and was tested in saline [9]. In 2010 a Siena team measured how four dialysis filters performed as ozone gas exchangers and reported ozone yields from 0 to 70 percent across them, along with changes to the fibers [10].
The equipment has kept changing since. The California clinic paper from 2023 calls its method “ozone dialysis”, the dialysis-filter form of EBOO [13]. Our what EBO2 is guide sets the Siena circuit and today’s clinic version side by side, and EBOO vs dialysis compares the filter version with hemodialysis.
How EBOO reached US clinics
By 2010 EBOO had a place in the ozone field’s own consensus document. The Madrid Declaration on Ozone Therapy first appeared on June 4, 2010, and its 2015 second edition lists EBOO among 24 recommended routes of administration [12].
The dated US record in our sources starts in the 2020s.
| Date | What happened | Source |
|---|---|---|
| Jun 4, 2010 | The Madrid Declaration on Ozone Therapy first appears | [12] |
| 2015 | Its second edition lists EBOO among 24 recommended routes | [12] |
| 2022 | The date one US clinic gives for when its physician began providing EBOO | [15] |
| 2023 | Practitioners at a Santa Rosa, California clinic publish ozone measurements from 12 patients and report at least 400 sessions | [13] |
| Jul 2023 | A Kansas practice begins offering EBOO, by its own account | [16] |
| 2025 | A New York case report follows an 88-year-old woman through two series of EBOO | [14] |
The California paper reports ozone measurements from 12 patients and says the clinic group had run at least 400 sessions [13]. Its authors also write that the method has been in use “for decades, at least 22 years in Malaysia alone” [13]. That statement rests on a reference we have not read ourselves.
Clinic websites fill in more of the picture. One clinic says its physician has provided EBOO since 2022 [15]. A Kansas practice began offering it in July 2023 [16]. A Bay Area practice says it has offered EBOO for more than five years [17], and another clinic says it has performed more than 2,000 EBOO treatments in the past three years [18].
Two parts of the story are missing from the sources. We found nothing that says who first offered EBOO in the United States or when, and nothing that says who first used the name EBO2. The Siena papers use EBOO throughout. Clinics today use both names, and this site treats them as one treatment.
Where EBO2 is offered today
EBO2 started in one hospital department in Tuscany and is now offered by clinics around the United States. As of November 18, 2026, our clinic directory lists 175 US clinics, sorted by state and city.
If the history has you curious about the treatment itself, these guides are the next step:
- What EBO2 is explains the procedure from start to finish.
- What to expect walks through a visit.
- What the published research reports goes through each study, and the research library holds our notes on the papers.
Good to know
Ozone therapy, including EBO2, is not FDA-approved. Talk to your doctor before you book, tell the clinic about your health conditions and every medicine you take, and keep taking any treatment you have been prescribed. The contraindications guide explains who should check first.
Frequently asked questions
Who invented EBOO?
A group at the University of Siena and the Siena hospital's nephrology and dialysis department, led in its clinical papers by the nephrologist Nicola Di Paolo, with the physiologist Velio Bocci as co-author of most of them. They began ozonating blood in an extracorporeal circuit in 1990, published their method in 1999 and the first report in patients in 2000.
When was EBOO first used in people?
The first published report in patients appeared in 2000. One of the authors volunteered first, and a patient with Madelung disease and several patients with atherosclerotic vascular disease followed. By 2002 the Siena group wrote that EBOO was used routinely in its hospital.
When did EBO2 come to the United States?
The sources do not give a first date. A Santa Rosa, California clinic reported at least 400 sessions in a 2023 paper, and clinics give their own start dates on their websites, from 2022 to more than five years ago.
Where does the name EBO2 come from?
We could not find who first used it or when. The Siena papers use EBOO throughout. Today clinics use both names, and this site treats EBO2 and EBOO as one treatment.
Where is EBO2 offered today?
Across the United States. As of November 18, 2026, our clinic directory lists 175 US clinics, sorted by state and city.
Sources
- Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. International Journal of Artificial Organs (PubMed), 2005. Peer-reviewed Our notes on this study: Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease
- Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies. International Journal of Artificial Organs (PubMed), 1999. Peer-reviewed Our notes on this study: Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies
- Extracorporeal blood oxygenation and ozonation (EBOO) in man. Preliminary report. International Journal of Artificial Organs (PubMed), 2000. Peer-reviewed Our notes on this study: Extracorporeal blood oxygenation and ozonation (EBOO) in man. Preliminary report
- Historical Highlights of Ozone Therapy. Journal of Pharmacy & Bioallied Sciences (PubMed Central), 2025. Peer-reviewed
- Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy. Redox Report (PubMed), 2005. Peer-reviewed Our notes on this study: Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy
- Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells. Translational Medicine Communications (PubMed Central), 2022. Peer-reviewed
- Ozonation of blood during extracorporeal circulation. II. Comparative analysis of several oxygenator-ozonators and selection of one type. International Journal of Artificial Organs (PubMed), 2001. Peer-reviewed Our notes on this study: Ozonation of blood during extracorporeal circulation. II. Comparative analysis of several oxygenator-ozonators and selection of one type
- Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO). International Journal of Artificial Organs (PubMed), 2002. Peer-reviewed Our notes on this study: Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO)
- Oxygenation-ozonation of blood during extracorporeal circulation: in vitro efficiency of a new gas exchange device. Artificial Organs (PubMed), 2007. Peer-reviewed Our notes on this study: Oxygenation-ozonation of blood during extracorporeal circulation: in vitro efficiency of a new gas exchange device
- Are dialysis devices usable as ozone gas exchangers?. Artificial Organs (PubMed), 2010. Peer-reviewed Our notes on this study: Are dialysis devices usable as ozone gas exchangers?
- Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects. Medical Gas Research (PubMed Central), 2011. Peer-reviewed
- Madrid Declaration on Ozone Therapy, 2nd edition (index of routes). ISCO3 (International Scientific Committee of Ozone Therapy), 2015. Other
- Ozone dialysis delivers three or more times the ozone than other forms of ozone blood treatment. Medical Gas Research (PubMed Central), 2023. Peer-reviewed
- Observed Reduction in Urinary Toxin Excretion With Extracorporeal Blood Oxygenation and Ozonation (EBOO) Treatment in an 88-Year-Old With Chronic Anemia: A Case Report. Cureus (PubMed Central), 2025. Peer-reviewed
- Full-spectrum EBOO Therapy in Lake Oswego, Oregon. Evergreen Factor, 2026. Clinic-stated
- EBOO Therapy. in2GREAT (Overland Park, KS), 2026. Clinic-stated
- EBOO Therapy (EBO2 service page). Biohackr Health, 2026. Clinic-stated
- Extracorporeal Oxygenation & Ozoniation. Advanced IV Health, 2026. Clinic-stated
- [The development of extracorporeal therapy of blood with oxygen, UV rays and ozone] (PubMed record, title only). Medizinische Klinik (PubMed), 1960. Peer-reviewed